Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog.

Abstract

A modified growth hormone releasing factor (GRF; TH9507), a 44 amino acid peptide analogue of natural human growth hormone releasing factor, is being developed for the treatment of age-associated conditions resulting from diminished growth hormone (GH) secretion. The inhalation route of administration is being considered as an alternative to subcutaneous… (More)

Topics

  • Presentations referencing similar topics